\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	the\\ initial\\ exam\\ revealed\\ small\\ almost\\ guttate\\ lesions\\ of\\ erythema\\ and\\ scale\\ with\\ follicular\\ prominence\\ scattered\\ over\\ his\\ back\\,\\ shoulders\\,\\ and\\ anterior\\ chest\\.\\ these\\ lesions\\ progressed\\ to\\ involve\\ his\\ upper\\ arms\\,\\ abdomen\\,\\ thighs\\,\\ and\\ lower\\ legs\\.\\ later\\ examination\\ revealed\\ annular\\ patches\\ measuring\\ from\\ 1\\-5\\ cm\\ scattered\\ among\\ the\\ smaller\\ lesions\\,\\ with\\ the\\ periphery\\ of\\ these\\ patches\\ and\\ intervening\\ skin\\ demonstrating\\ prominent\\ follicular\\ hyperkeratosis\\.\ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ first\\ fungal\\ culture\\:\\ scopulariopsis\\ \\(considered\\ to\\ be\\ a\\ contaminant\\)\\.\\ \ \(0\)\
\-\ second\\ fungal\\ culture\\:\\ negative\\.\ \(0\)\
\-\ third\\ fungal\\ culture\\ \\(done\\ on\\ tissue\\)\\:\\ negative\\.\ \(0\)\
\-\ rpr\\ and\\ hiv\\ negative\\,\\ cbc\\ and\\ chemistries\\ normal\\,\\ ua\\ normal\\.\ \(0\)\
\-\ histopathology\\:\\	sections\\ demonstrated\\ psoriasiform\\ epidermal\\ hyperplasia\\ with\\ hyperkeratosis\\,\\ parakeratosis\\,\\ and\\ follicular\\ keratotic\\ plugging\\.\\ there\\ was\\ minimal\\ dermal\\ inflammation\\.\ \(0\)\
\-\ the\\ patient\\ was\\ started\\ on\\ accutane\\,\\ 80mg\\/day\\ and\\ after\\ one\\ month\\ showed\\ no\\ improvement\\.\\ the\\ patient\\ was\\ not\\ able\\ to\\ tolerate\\ lachydrin\\ lotion\\ because\\ of\\ the\\ stinging\\ sensation\\.\\ the\\ patient\\ is\\ currently\\ on\\ accutane\\ 160\\ mg\\/day\\.\ \(0\)\
\-\ pityriasis\\ rubra\\ pilaris\\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#3\\)\\ presented\\ by\\:\\ rinna\\ c\\.\\ johnson\\,\\ maj\\,\\ mc\\,\\ usa\ \(0\)\
\-\ patient\\ presented\\ with\\ a\\ 3\\-4\\ year\\ history\\ of\\ a\\ chest\\ and\\ back\\ rash\\ that\\ had\\ been\\ treated\\ with\\ topical\\ selsun\\ and\\ antifungals\\ without\\ improvement\\.\\ due\\ to\\ a\\ new\\ crop\\ of\\ lesions\\ on\\ his\\ upper\\ arms\\ and\\ thighs\\,\\ he\\ sought\\ a\\ new\\ consultation\\ with\\ dermatology\\.\\ initial\\ koh\\ was\\ positive\\ and\\ the\\ patient\\ was\\ treated\\ with\\ a\\ 2\\ week\\ course\\ of\\ oral\\ ketoconazole\\ but\\ with\\ no\\ improvement\\.\\ the\\ first\\ fungal\\ culture\\ grew\\ out\\ scopulariopsis\\ ssp\\ and\\ a\\ shave\\ biopsy\\ showed\\ a\\ psoriasiform\\ dermatitis\\ with\\ negative\\ pas\\ stain\\.\\ because\\ of\\ persistence\\ of\\ lesions\\,\\ the\\ patient\\ was\\ recultured\\ 2\\ weeks\\ after\\ the\\ last\\ ketoconazole\\ and\\ this\\ second\\ culture\\ was\\ negative\\.\\ while\\ awaiting\\ culture\\ results\\,\\ the\\ patient\\ was\\ treated\\ with\\ an\\ empiric\\ course\\ of\\ oral\\ itraconazole\\.\\ the\\ patient\\ developed\\ new\\ lesions\\ while\\ on\\ itraconazole\\,\\ so\\ a\\ 4\\ mm\\ punch\\ biopsy\\ was\\ performed\\ which\\ showed\\ findings\\ suggestive\\ of\\ small\\ plaque\\ parapsoriasis\\.\\ the\\ patient\\ was\\ started\\ on\\ uvb\\ therapy\\ and\\ topical\\ kenalog\\ spray\\.\\ the\\ uvb\\ therapy\\ was\\ discontinued\\ due\\ to\\ noncompliance\\ because\\ of\\ college\\ classes\\ and\\ work\\.\\ he\\ showed\\ no\\ improvement\\ with\\ this\\ therapy\\.\\ when\\ patches\\ began\\ to\\ enlarge\\,\\ an\\ incisional\\ biopsy\\ was\\ performed\\ which\\ showed\\ changes\\ consistent\\ with\\ pityriasis\\ rubra\\ pilaris\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ culture\\:\\ 0\\.26227533042582996\ \(0\)\
\-\ was\\:\\ 0\\.1887388020634551\ \(0\)\
\-\ patches\\:\\ 0\\.1720916689195595\ \(0\)\
\-\ fungal\\:\\ 0\\.16158834436877215\ \(0\)\
\-\ improvement\\:\\ 0\\.15757717119229514\ \(0\)\
\-\ lesions\\:\\ 0\\.15551184468197793\ \(0\)\
\-\ follicular\\:\\ 0\\.15474446821816165\ \(0\)\
\-\ showed\\:\\ 0\\.15029868016526352\ \(0\)\
\-\ and\\:\\ 0\\.1492088179753635\ \(0\)\
\-\ scopulariopsis\\:\\ 0\\.14434522168728325\ \(0\)\
\-\ psoriasiform\\:\\ 0\\.14434522168728325\ \(0\)\
\-\ pilaris\\:\\ 0\\.14434522168728325\ \(0\)\
\-\ uvb\\:\\ 0\\.14434522168728325\ \(0\)\
\-\ negative\\:\\ 0\\.13969820979685968\ \(0\)\
\-\ accutane\\:\\ 0\\.13792956535571843\ \(0\)\
\-\ pityriasis\\:\\ 0\\.13792956535571843\ \(0\)\
\-\ rubra\\:\\ 0\\.13792956535571843\ \(0\)\
\-\ ketoconazole\\:\\ 0\\.13792956535571843\ \(0\)\
\-\ the\\:\\ 0\\.13507589687399627\ \(0\)\
\-\ patient\\:\\ 0\\.13210655707458552\ \(0\)\
\-\ hyperkeratosis\\:\\ 0\\.12696192841547793\ \(0\)\
\-\ itraconazole\\:\\ 0\\.1205462720839131\ \(0\)\
\-\ thighs\\:\\ 0\\.11355517213975824\ \(0\)\
\-\ topical\\:\\ 0\\.10713951580819342\ \(0\)\
\-\ with\\:\\ 0\\.10604409509923286\ \(0\)\
\-\ of\\:\\ 0\\.09714904064566035\ \(0\)\
\-\ biopsy\\:\\ 0\\.09490345207084704\ \(0\)\
\-\ because\\:\\ 0\\.0946225679271242\ \(0\)\
\-\ new\\:\\ 0\\.09366485280157179\ \(0\)\
\-\ arms\\:\\ 0\\.09106464987013571\ \(0\)\
\-\ dermatology\\:\\ 0\\.0883167801450009\ \(0\)\
\-\ treated\\:\\ 0\\.08431108067408337\ \(0\)\
\-\ his\\:\\ 0\\.08211067566370499\ \(0\)\
\-\ on\\:\\ 0\\.08178011269821199\ \(0\)\
\-\ scattered\\:\\ 0\\.07853940004584017\ \(0\)\
\-\ therapy\\:\\ 0\\.07779024546068852\ \(0\)\
\-\ started\\:\\ 0\\.07602979972334006\ \(0\)\
\-\ oral\\:\\ 0\\.07228943062530643\ \(0\)\
\-\ contaminant\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ keratotic\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ lachydrin\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ stinging\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ selsun\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ crop\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ koh\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ ssp\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ recultured\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ parapsoriasis\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ noncompliance\\:\\ 0\\.07217261084364163\ \(0\)\
\-\ guttate\\:\\ 0\\.06896478267785922\ \(0\)\
\-\ parakeratosis\\:\\ 0\\.06896478267785922\ \(0\)\
\-\ rinna\\:\\ 0\\.06896478267785922\ \(0\)\
\-\ kenalog\\:\\ 0\\.06896478267785922\ \(0\)\
\-\ spray\\:\\ 0\\.06896478267785922\ \(0\)\
\-\ to\\:\\ 0\\.06769438933193242\ \(0\)\
\-\ second\\:\\ 0\\.06757176310559965\ \(0\)\
\-\ lotion\\:\\ 0\\.06668879237352136\ \(0\)\
\-\ course\\:\\ 0\\.06667078224504157\ \(0\)\
\-\ shave\\:\\ 0\\.06492339714072744\ \(0\)\
\-\ chemistries\\:\\ 0\\.06348096420773897\ \(0\)\
\-\ antifungals\\:\\ 0\\.06348096420773897\ \(0\)\
\-\ johnson\\:\\ 0\\.062261404539999385\ \(0\)\
\-\ classes\\:\\ 0\\.062261404539999385\ \(0\)\
\-\ incisional\\:\\ 0\\.061204973903401114\ \(0\)\
\-\ first\\:\\ 0\\.06091078472159155\ \(0\)\
\-\ initial\\:\\ 0\\.060549789092285505\ \(0\)\
\-\ pas\\:\\ 0\\.06027313604195655\ \(0\)\
\-\ back\\:\\ 0\\.0601968460854392\ \(0\)\
\-\ intervening\\:\\ 0\\.059439578670607174\ \(0\)\
\-\ empiric\\:\\ 0\\.059439578670607174\ \(0\)\
\-\ revealed\\:\\ 0\\.05918292919250196\ \(0\)\
\-\ punch\\:\\ 0\\.05868553430736066\ \(0\)\
\-\ while\\:\\ 0\\.05833317036255008\ \(0\)\
\-\ college\\:\\ 0\\.056231750504824755\ \(0\)\
\-\ enlarge\\:\\ 0\\.056231750504824755\ \(0\)\
\-\ rpr\\:\\ 0\\.05572115543328086\ \(0\)\
\-\ sought\\:\\ 0\\.05572115543328086\ \(0\)\
\-\ discontinued\\:\\ 0\\.05572115543328086\ \(0\)\
\-\ plugging\\:\\ 0\\.05524152508898305\ \(0\)\
\-\ maj\\:\\ 0\\.05524152508898305\ \(0\)\
\-\ usa\\:\\ 0\\.05436156595580793\ \(0\)\
\-\ dermatitis\\:\\ 0\\.05436156595580793\ \(0\)\
\-\ tolerate\\:\\ 0\\.05395576020048691\ \(0\)\
\-\ epidermal\\:\\ 0\\.05356975790409671\ \(0\)\
\-\ he\\:\\ 0\\.05344860124324809\ \(0\)\
\-\ performed\\:\\ 0\\.05339804862700806\ \(0\)\
\-\ awaiting\\:\\ 0\\.0532017158372404\ \(0\)\
\-\ dermal\\:\\ 0\\.052850036708403124\ \(0\)\
\-\ presented\\:\\ 0\\.05263445826225044\ \(0\)\
\-\ sections\\:\\ 0\\.052513327267498446\ \(0\)\
\-\ 160\\:\\ 0\\.052513327267498446\ \(0\)\
\-\ persistence\\:\\ 0\\.052513327267498446\ \(0\)\
\-\ due\\:\\ 0\\.05188307885869146\ \(0\)\
\-\ grew\\:\\ 0\\.051293767599758865\ \(0\)\
\-\ these\\:\\ 0\\.05096974840677021\ \(0\)\
\-\ annular\\:\\ 0\\.04908873272809571\ \(0\)\
\-\ stain\\:\\ 0\\.04908873272809571\ \(0\)\
\-\ shoulders\\:\\ 0\\.04867224300395049\ \(0\)\
\-\ rash\\:\\ 0\\.04867224300395049\ \(0\)\
\-\ upper\\:\\ 0\\.048233490017837104\ \(0\)\
\-\ prominence\\:\\ 0\\.04771789736712014\ \(0\)\
\-\ among\\:\\ 0\\.04771789736712014\ \(0\)\
\-\ chest\\:\\ 0\\.04764374639937186\ \(0\)\
\-\ mc\\:\\ 0\\.04736621823828286\ \(0\)\
\-\ plaque\\:\\ 0\\.04736621823828286\ \(0\)\
\-\ progressed\\:\\ 0\\.04686637976623687\ \(0\)\
\-\ small\\:\\ 0\\.04655909365723535\ \(0\)\
\-\ periphery\\:\\ 0\\.045532324935067855\ \(0\)\
\-\ histopathology\\:\\ 0\\.045532324935067855\ \(0\)\
\-\ consultation\\:\\ 0\\.045532324935067855\ \(0\)\
\-\ exam\\:\\ 0\\.04543687627164769\ \(0\)\
\-\ seminar\\:\\ 0\\.04539708270654687\ \(0\)\
\-\ scale\\:\\ 0\\.04500469761214045\ \(0\)\
\-\ uniformed\\:\\ 0\\.04500469761214045\ \(0\)\
\-\ hiv\\:\\ 0\\.0446308574668187\ \(0\)\
\-\ 1997\\:\\ 0\\.0446308574668187\ \(0\)\
\-\ legs\\:\\ 0\\.04439109736973271\ \(0\)\
\-\ services\\:\\ 0\\.04427388814874253\ \(0\)\
\-\ no\\:\\ 0\\.04402723620044138\ \(0\)\
\-\ after\\:\\ 0\\.04378655467150294\ \(0\)\
\-\ ua\\:\\ 0\\.04308764001531979\ \(0\)\
\-\ began\\:\\ 0\\.04196886486609065\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.04114400620668081\ \(0\)\
\-\ which\\:\\ 0\\.04104207228485905\ \(0\)\
\-\ erythema\\:\\ 0\\.04083672573106225\ \(0\)\
\-\ smaller\\:\\ 0\\.040613852465813366\ \(0\)\
\-\ almost\\:\\ 0\\.04054093510437177\ \(0\)\
\-\ involve\\:\\ 0\\.03971463930095942\ \(0\)\
\-\ able\\:\\ 0\\.03958494004030475\ \(0\)\
\-\ sensation\\:\\ 0\\.038674571602380185\ \(0\)\
\-\ so\\:\\ 0\\.03796233171004501\ \(0\)\
\-\ cbc\\:\\ 0\\.03765405331846751\ \(0\)\
\-\ demonstrating\\:\\ 0\\.037213051862276414\ \(0\)\
\-\ normal\\:\\ 0\\.03685250989731773\ \(0\)\
\-\ work\\:\\ 0\\.03679534019393046\ \(0\)\
\-\ suggestive\\:\\ 0\\.03675026042687962\ \(0\)\
\-\ last\\:\\ 0\\.03670543607064419\ \(0\)\
\-\ inflammation\\:\\ 0\\.036270630082581815\ \(0\)\
\-\ done\\:\\ 0\\.03589874282599635\ \(0\)\
\-\ prominent\\:\\ 0\\.03554355450317297\ \(0\)\
\-\ considered\\:\\ 0\\.035166746255129486\ \(0\)\
\-\ results\\:\\ 0\\.035166746255129486\ \(0\)\
\-\ measuring\\:\\ 0\\.03491326762207279\ \(0\)\
\-\ currently\\:\\ 0\\.03466765878955917\ \(0\)\
\-\ an\\:\\ 0\\.034515080856732466\ \(0\)\
\-\ minimal\\:\\ 0\\.03442944576630635\ \(0\)\
\-\ third\\:\\ 0\\.03436268184510028\ \(0\)\
\-\ skin\\:\\ 0\\.03357245688048028\ \(0\)\
\-\ developed\\:\\ 0\\.03348272271192516\ \(0\)\
\-\ laboratory\\:\\ 0\\.032772058732689555\ \(0\)\
\-\ later\\:\\ 0\\.03229722758642304\ \(0\)\
\-\ mm\\:\\ 0\\.03229722758642304\ \(0\)\
\-\ this\\:\\ 0\\.031014925357972598\ \(0\)\
\-\ week\\:\\ 0\\.030354607842285327\ \(0\)\
\-\ positive\\:\\ 0\\.029738317586840177\ \(0\)\
\-\ out\\:\\ 0\\.02966455036045787\ \(0\)\
\-\ examination\\:\\ 0\\.02887886337498002\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02773565149117147\ \(0\)\
\-\ abdomen\\:\\ 0\\.027536788798864797\ \(0\)\
\-\ month\\:\\ 0\\.02745306867675054\ \(0\)\
\-\ changes\\:\\ 0\\.027274658323247356\ \(0\)\
\-\ when\\:\\ 0\\.027261099660610893\ \(0\)\
\-\ weeks\\:\\ 0\\.02704726292142952\ \(0\)\
\-\ been\\:\\ 0\\.026293218558183007\ \(0\)\
\-\ cm\\:\\ 0\\.025918640780329658\ \(0\)\
\-\ one\\:\\ 0\\.02583901344534025\ \(0\)\
\-\ anterior\\:\\ 0\\.025197925493070768\ \(0\)\
\-\ over\\:\\ 0\\.025094234916897152\ \(0\)\
\-\ physical\\:\\ 0\\.024470493525885127\ \(0\)\
\-\ consistent\\:\\ 0\\.024470493525885127\ \(0\)\
\-\ without\\:\\ 0\\.023804350539783085\ \(0\)\
\-\ tissue\\:\\ 0\\.02367415323429745\ \(0\)\
\-\ lower\\:\\ 0\\.023061452468806747\ \(0\)\
\-\ case\\:\\ 0\\.02267279486857824\ \(0\)\
\-\ had\\:\\ 0\\.022485399141309936\ \(0\)\
\-\ but\\:\\ 0\\.022316829552215325\ \(0\)\
\-\ findings\\:\\ 0\\.022273439254904267\ \(0\)\
\-\ that\\:\\ 0\\.019584704764373934\ \(0\)\
\-\ by\\:\\ 0\\.019164793120749778\ \(0\)\
\-\ be\\:\\ 0\\.0183074154968126\ \(0\)\
\-\ there\\:\\ 0\\.01795706604406061\ \(0\)\
\-\ from\\:\\ 0\\.017923701829248812\ \(0\)\
\-\ not\\:\\ 0\\.01781622973745352\ \(0\)\
\-\ history\\:\\ 0\\.017242252543972426\ \(0\)\
\-\ year\\:\\ 0\\.013908161281545468\ \(0\)\
\-\ is\\:\\ 0\\.01235914273142767\ \(0\)\
